Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
microRNA Expression Profiling After Dexmedetomidine in Procedures
NCT03213743Completed
- Sponsor
- First Affiliated Hospital of Kunming Medical University
- Start
- Jun 2017
- Primary completion
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of dexmedetomidine in coronary artery disease (CAD), sponsored by First Affiliated Hospital of Kunming Medical University. Primary endpoint: microRNA differential expression at 30 minutes. Started Jun 2017; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT03213743.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03213743.